World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
50
Citations
7727
World Ranking
5808
National Ranking
2558

Overview

Duygu Tosun is affiliated with the University of California, San Francisco in the United States. Their research spans multiple fields within medicine and neuroscience, focusing particularly on neurodegenerative diseases and neuroimaging techniques.

The main fields of study for Tosun include Medicine and Neuroscience, with subfields in Psychiatry and Mental Health, Physiology, Cognitive Neuroscience, Radiology, Nuclear Medicine and Imaging, and Neurology. Their research topics cover a range of areas such as Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies, Advanced Neuroimaging Techniques and Applications, Parkinson's Disease Mechanisms and Treatments, Neurological Disease Mechanisms and Treatments, and Medical Imaging Techniques and Applications.

Tosun has published extensively in the following venues:

  • Alzheimer's & Dementia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • American Journal of Geriatric Psychiatry
  • JAMA Neurology
  • Translational Psychiatry

Among recent notable papers are:

  • ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease (2021, Nature Aging)
  • Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease (2021, Alzheimer's & Dementia)
  • Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression (2022, JAMA Psychiatry)
  • Head-to-head comparison of leading blood tests for Alzheimer's disease pathology (2024, Alzheimer's & Dementia)
  • Late-Life Depression Is Associated With Reduced Cortical Amyloid Burden: Findings From the Alzheimer's Disease Neuroimaging Initiative Depression Project (2020, Biological Psychiatry)

Frequent coauthors include Andrew J. Saykin, Clifford R. Jack, Michael W. Weiner, Leslie M. Shaw, and Arthur W. Toga.

Best Publications

  • Update on the Magnetic Resonance Imaging core of the Alzheimer's Disease Neuroimaging Initiative

    C.R. Jack;M.A. Bernstein;B.J. Borowski;J.L. Gunter

  • Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases

    Matthew J Betts;Matthew J Betts;Evgeniya Kirilina;Evgeniya Kirilina;Maria C G Otaduy;Dimo Ivanov

  • CRUISE: cortical reconstruction using implicit surface evolution.

    Xiao Han;Dzung L. Pham;Duygu Tosun;Maryam E. Rettmann

  • Cortical Thickness, Surface Area and Volume of the Brain Reward System in Alcohol Dependence: Relationships to Relapse and Extended Abstinence

    Timothy C. Durazzo;Duygu Tosun;Shannon Buckley;Stefan Gazdzinski

  • Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer’s Disease

    Ashish Raj;Eve LoCastro;Amy Kuceyeski;Duygu Tosun

  • Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer’s disease and mild cognitive impairment

    Niklas Mattsson;Niklas Mattsson;Niklas Mattsson;Duygu Tosun;Duygu Tosun;Philip S. Insel;Philip S. Insel;Alix Simonson;Alix Simonson

  • Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort

    Tanya Simuni;Andrew Siderowf;Shirley Lasch;Chris S. Coffey

  • Locally linear embedding (LLE) for MRI based Alzheimer's disease classification.

    Xin Liu;Duygu Tosun;Michael W Weiner;Norbert Schuff

  • Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease.

    Dallas P. Veitch;Michael W. Weiner;Paul S. Aisen;Laurel A. Beckett

  • Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression.

    Unknown

  • ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease

    Petr Novak;Branislav Kovacech;Stanislav Katina;Reinhold Schmidt

  • Spatial patterns of brain amyloid-β burden and atrophy rate associations in mild cognitive impairment

    Duygu Tosun;Norbert Schuff;Chester A. Mathis;William Jagust

  • Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4

    Unknown

  • Increased Cortical Thickness in Male-to-Female Transsexualism

    Eileen Luders;Francisco J. Sánchez;Duygu Tosun;David W. Shattuck

  • Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study

    Duygu Tosun;Norbert Schuff;Norbert Schuff;Diana Truran-Sacrey;Leslie M. Shaw

  • Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study

    Tanya Simuni;Liz Uribe;Hyunkeun Ryan Cho;Chelsea Caspell-Garcia

  • Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.

    Duygu Tosun;Susan Landau;Paul S Aisen;Ronald C Petersen

  • Effects of traumatic brain injury and posttraumatic stress disorder on development of Alzheimer's disease in Vietnam Veterans using the Alzheimer's Disease Neuroimaging Initiative: Preliminary report

    Michael W. Weiner;Michael W. Weiner;Danielle Harvey;Jacqueline Hayes;Susan M. Landau

  • Mapping techniques for aligning sulci across multiple brains.

    Duygu Tosun;Maryam E. Rettmann;Jerry L. Prince

  • Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects

    G. C. Chiang;G. C. Chiang;P. S. Insel;D. Tosun;D. Tosun;N. Schuff;N. Schuff

  • Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer's disease and frontotemporal dementia.

    Yu Zhang;Norbert Schuff;Christopher Ching;Duygu Tosun

  • Nonlinear time course of brain volume loss in cognitively normal and impaired elders

    Norbert Schuff;Norbert Schuff;Duygu Tosun;Philip S. Insel;Gloria C. Chiang;Gloria C. Chiang

Frequent Co-Authors

Michael W. Weiner
Michael W. Weiner University of California, San Francisco
Philip S. Insel
Philip S. Insel University of California, San Francisco
Clifford R. Jack
Clifford R. Jack Mayo Clinic
Charles DeCarli
Charles DeCarli University of California, Davis
Paul M. Thompson
Paul M. Thompson University of Southern California
William J. Jagust
William J. Jagust University of California, Berkeley
Arthur W. Toga
Arthur W. Toga University of Southern California
R. Scott Mackin
R. Scott Mackin University of California, San Francisco
John Q. Trojanowski
John Q. Trojanowski University of Pennsylvania
Susanne G. Mueller
Susanne G. Mueller University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Duygu Tosun

Trending Scientists